Kynam Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-442,704
| Closed | -$3.52M | – | 22 |
|
|
2023
Q4 | $3.52M | Sell |
442,704
-287,768
| -39% | -$2.29M | 0.39% | 23 |
|
|
2023
Q3 | $4.73M | Buy |
730,472
+1,395
| +0.2% | +$9.03K | 0.77% | 21 |
|
|
2023
Q2 | $4.51M | Hold |
729,077
| – | – | 0.62% | 18 |
|
|
2023
Q1 | $2.81M | Sell |
729,077
-4,849
| -0.7% | -$18.7K | 0.36% | 25 |
|
|
2022
Q4 | $2.28M | Buy |
733,926
+2,405
| +0.3% | +$7.46K | 0.35% | 26 |
|
|
2022
Q3 | $2.94M | Sell |
731,521
-26,327
| -3% | -$106K | 0.62% | 26 |
|
|
2022
Q2 | $3.69M | Buy |
757,848
+88,748
| +13% | +$432K | 0.94% | 20 |
|
|
2022
Q1 | $6M | Buy |
669,100
+430,059
| +180% | +$3.86M | 1.95% | 16 |
|
|
2021
Q4 | $2.69M | Buy |
+239,041
| New | +$2.69M | 1.44% | 20 |
|